Similarly, EPRS was found to be highly expressed in estrogen receptor positive (ER+) breast cancer tissues and was associated with reduced overall survival in TCGA and METABRIC datasets (Katsyv et al., 2016). Here, EPRS1 is linked to breast cancer.